Amgen reported $37.35B in Loan Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
ALKERMES ALKS:US USD 290.9M 633K
Amgen AMGN:US USD 37.35B 193M
Astrazeneca AZN:US USD 23.68B 3.47B
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Genmab GEN:DC DKK 550M 4M
Glaxosmithkline GSK:US GBP 17.04B 2.29B
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
Moderna Inc MRNA:US USD 922M 281M
Novartis NVS:US USD 21.78B 547M
Novartis NOVN:VX USD 21.78B 547M
Ptc Therapeutics PTCT:US USD 981.61M 165K
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Roche Holding ROG:VX 22.37B 6.29B
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Takeda 4502:JP JPY 3.91T 253.53B
Teva Pharmaceutical TEVA:IT USD 18.5B 1.87B